ERS’s Risk Ratings: A Proven System for Identifying Danger Before It Strikes
While many investors in 2021 were still optimistic about PATH’s long-term potential, ERS’s system flagged profound risk. And the data proved correct—by March 2022, PATH had plummeted to $30.